Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sandip Vasavada, MD, serves as the Urologic Director, Center for Female Urology and Reconstructive Pelvic Surgery, at Cleveland Clinic within the Glickman Urological Institute. Together with his other colleagues he helps represent one of the largest centers for female urology and reconstructive genitourinary surgery in the country. He is also Professor of Surgery (Urology) at the Cleveland Clinic Lerner College of Medicine and has a joint appointment with the Women's Institute.
Dr. Vasavada completed his medical school training in the competitive six-year combined BS/MD program at Northeastern Ohio Universities College of Medicine in 1991. Upon graduation, he began his urology residency at Cleveland Clinic and graduated the residency in 1997. Subsequently, he began a fellowship in female urology, neuro-urology and reconstruction at the UCLA School of Medicine in Los Angeles, Calif. He then took a position as Assistant Professor of Urology at Thomas Jefferson Medical College in Philadelphia prior to returning to Cleveland in 2001.
Dr. Vasavada has published numerous manuscripts and book chapters in the area of voiding dysfunction and urinary incontinence and has been named to "Top Docs" in Philadelphia and Cleveland magazines for over 15 years. He has published three textbooks, the first entitled Female Urology, Urogynecology and Voiding Dysfunction (Marcel-Dekker, N.Y., 2005) and his second book on Female Urology and Pelvic Organ Prolapse with co-author Howard Goldman, MD (Humana Publishing, 2007) and just completed his third textbook entitled Complex Cases in Female Urology and Reconstruction. He has authored over 100 manuscripts and over 25 book chapters and numerous abstracts and videos . He has lectured and demonstrated surgical techniques around the world in over 20 countries. Dr Vasavada is a reviewer for seven major journals in the field of urology, urogynecology and voiding dysfunction. He serves on the American Board of Urology Exam Committee and has helped author American Urological Association (AUA) Guidelines in Overactive Bladder and now helping with Stress Urinary Incontinence for the country.
Dr. Vasavada's main clinical interests lie in the area of urinary incontinence, pelvic organ prolapse and complex reconstruction of the lower urinary tract and management of complications of vaginal and lower urinary tract surgery. His current research interests are in the field of refractory bladder overactivity and neuromodulation and care pathways for optimizing care in patients undergoing incontinence and prolapse surgery. Dr. Vasavada serves with the Section of Urogynecology on the NIH-Pelvic Floor Disorders Network.
Complex pelvic reconstruction, complications of vaginal surgery, female urology, male incontinence, neuromodulation, prolapse, prolapse surgery, urethrovaginal reconstruction, urinary incontinence, neuromodulation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/23/2015, Dr. Vasavada has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.